Related Experiment Videos
Summary
Furosemide effectively increased urine output in infants with hyaline membrane disease but did not improve cardiorespiratory function. This potent diuretic effect did not alter pulmonary interstitial fluid or gas exchange acutely.
Area of Science:
- Neonatal Medicine
- Pediatric Cardiology
- Pharmacology
Background:
- Hyaline membrane disease (HMD) is a significant respiratory distress condition in premature infants.
- Cardiorespiratory function is often compromised in infants with HMD.
- The role of fluid management and diuresis in acute HMD is not fully understood.
Purpose of the Study:
- To evaluate the acute effects of furosemide-induced diuresis on cardiorespiratory function in infants with HMD.
- To assess the impact of diuresis on fluid balance and electrolyte loss in this population.
- To investigate potential mechanisms for furosemide's efficacy or lack thereof in HMD.
Main Methods:
- A randomized clinical trial comparing furosemide (2 mg/kg IV) to placebo (dextrose water) in infants with HMD.
- Arterial blood gas analyses were performed pre- and post-treatment.
- Urine output, electrolytes, echocardiography (left atrial size), and skinfold thickness were measured.
Main Results:
- Furosemide significantly increased urine output, sodium, and calcium excretion (P < .05).
- No significant differences in arterial blood gases or left atrial size were observed between groups.
- Subcutaneous water mobilization was suggested, but one infant experienced dehydration and hypotension.
Conclusions:
- Furosemide exerts a potent diuretic effect in infants with HMD.
- Acute cardiorespiratory function and gas exchange were not improved by furosemide.
- Pulmonary interstitial fluid mobilization may not occur rapidly enough or may not be a primary factor in acute HMD gas exchange impairment.